Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer

---

Akun E., Okutur K., Seber S., Korkmaz T., Aydin K., Bozkurt M., ...More

JOURNAL OF BUON, vol.17, no.4, pp.669-676, 2012 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 17 Issue: 4
• Publication Date: 2012
• Journal Name: JOURNAL OF BUON
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.669-676
• Istanbul University Affiliated: Yes

Abstract

Purpose: To determine the clinical features of bevacizumab-associated toxicities in metastatic colorectal cancer (MCRC) patients.